Startups
Since 2009, Cytosurge AG develops, manufactures, and distributes state-of-the-art nanotechnology solutions and systems based on its patented FluidFM® technology.
At the heart of the technology are the hollow FluidFM probes, which have apertures down to 300 nm, enabling the handling of femtoliter volumes. With its FluidFM solutions Cytosurge brings significant benefits to a wide range of applications in life sciences. More than 100 labs are already using FluidFM systems and go beyond conventional technological boundaries in CRISPR genome editing, mechanobiology, virology, single cell omics, neuroscience, and nanoprinting.
We are driven by our common goal to enhance societal health and well-being by accelerating science through our unique solutions.
At the heart of the technology are the hollow FluidFM probes, which have apertures down to 300 nm, enabling the handling of femtoliter volumes. With its FluidFM solutions Cytosurge brings significant benefits to a wide range of applications in life sciences. More than 100 labs are already using FluidFM systems and go beyond conventional technological boundaries in CRISPR genome editing, mechanobiology, virology, single cell omics, neuroscience, and nanoprinting.
We are driven by our common goal to enhance societal health and well-being by accelerating science through our unique solutions.
Overview
Location
Switzerland, Zurich, Glattbrugg
Employees
11-50
Founded date
2009
Mentions in press and media 22
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 10, 2025 | New leadership propels startups towards accelerated growth | Jennifer Yohannes, the former CEO of Kartenmacherei, Europe's leading provider of personalized stationery, has joined Librio as its new Chief Product Officer. Jennifer Yohannes has many years of experience in building and scaling personali... |
| Sep 23, 2024 | Sequencing Cells without Killing Them Using Subcellular Biopsies, Upcoming Webinar Hosted by Xtalks | www.cytosurge.com/solutions/biopsy-platform-cytoplasmic-extraction In this free webinar, learn about the use of subcellular biopsies for cell sequencing and how live-seq can capture the molecular dynamics of a single cell. Attendees will le... |
| Mar 30, 2022 | Cytosurge launches cell line engineering services based on proprietary FluidFM technology | Cytosurge launches cell line engineering services based on proprietary FluidFM technology Wed, Mar 30, 2022 15:19 CET Report this content Zurich, March 30, 2022 – Cytosurge, a global leader in precision single cell manipulation, today an... |
| Jan 18, 2022 | R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisse | R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisse Tue, Jan 18, 2022 13:08 CET Innosuisse is co-funding the collaboration to address a... |
| Oct 5, 2020 | Startups win strong and well-connected board members | |
| Oct 5, 2020 | Startups win strong and well-connected board members | NBE Therapeutics, Erich Schlick, chairman of the board of Director NBE-Therapeutics, a biotech company developing best-in-class cancer therapies based on its proprietary, highly differentiated Antibody Drug Conjugate (ADC) platform, announc... |
| Jul 24, 2020 | Cytosurge collaborates with Olympus to enter the Americas | |
| Jul 24, 2020 | Cytosurge collaborates with Olympus to enter the Americas | Cytosurge develops, manufactures, and distributes state-of-the-art nanotechnology solutions and systems based on its patented FluidFM technology. At the heart of the technology are the hollow FluidFM probes, which have apertures down to 300... |
| Aug 22, 2019 | Cytosurge AG spins off its 3D printing business unit |
Show more
Reviews 0
FAQ about Cytosurge AG
When was Cytosurge AG founded?
Cytosurge AG was founded in 2009.
What has the press written about Cytosurge AG?
Parsers VC has collected 22 articles mentioning Cytosurge AG, among them “New leadership propels startups towards accelerated growth” (Apr 10, 2025) and “Sequencing Cells without Killing Them Using Subcellular Biopsies, Upcoming Webinar Hosted by Xtalks” (Sep 23, 2024).
Is Cytosurge AG still active?
Yes, Cytosurge AG is active; its latest activity on Parsers VC dates from Apr 10, 2025.